- ECT demonstrates beneficial effects on motor and nonmotor symptoms across movement disorders, with the most substantial evidence for Parkinson disease.
- Evidence is limited and primarily from case reports with constrained quantitative and qualitative rigour, necessitating standardised clinical trials.
- Data for Huntington disease and related disorders are inconclusive and may indicate potential negative effects of ECT.
J ECT. 2026 Jun 23. doi: 10.1097/YCT.0000000000001225. Online ahead of print.
ABSTRACT
Electroconvulsive therapy (ECT) is an established treatment strategy for a range of psychiatric disorders, including depression, mania, psychosis, and catatonia. A growing body of evidence suggests that ECT may affect motor symptoms in movement disorders. In a systematic review, we aim to review the evidence on the use of ECT in movement disorders. We searched PubMed, SCOPUS, Cochrane, Web of Science, and Embase to identify relevant publications. Fifty-eight papers were retained for data extraction. The existing evidence suggests a beneficial impact of ECT on both motor and nonmotor symptoms across various movement disorders, with the most substantial findings reported for Parkinson disease. Conversely, the evidence pertaining to Huntington disease and related disorders cannot rule out a potentially negative effect. Given that the data reviewed are constrained in both quantitative and qualitative rigor, predominantly derived from case reports, further research through the publication of case reports and the conduct of standardized clinical trials is warranted.
PMID:42325059 | DOI:10.1097/YCT.0000000000001225
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

